Does treatment of subsyndromal depression improve depression and diabetes related outcomes: Protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual

Trials

Volumn 12, Issue , 2011, Pages

  Pibernik Okanović, Mirjana ^a   Ajduković, Dea ^a   Lovrenčić, Marijana V ^a   Hermanns, Norbert ^b  

^a University of Zagreb   (Croatia)

^b Research Institute of the Diabetes Academy Mergentheim   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEPRESSION; EXERCISE; HUMAN; INTERVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOEDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCREENING; SELF CARE; SELF MONITORING; TREATMENT OUTCOME; ADOLESCENT; AFFECT; ATTITUDE TO HEALTH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROATIA; HEALTH BEHAVIOR; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; TIME;

ADOLESCENT; ADULT; AFFECT; AGED; CROATIA; DEPRESSION; DIABETES MELLITUS, TYPE 2; EXERCISE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; SELF CARE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651534230     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-17     Document Type: Article

References (39)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of co-morbid depression in adults with diabetes. Diabetes Care 2001, 24:1069-1078. 10.2337/diacare.24.6.1069, 11375373.
2. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003, 26:2822-2828. 10.2337/diacare.26.10.2822, 14514586.
3. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact on adherence, function and costs. Arch Intern Med 2000, 160:3278-3285. 10.1001/archinte.160.21.3278, 11088090.
4. Lin EH, Katon W, Von Korff M, Rutter C, Simon GE, Oliver M, Ciechanowski P, Ludman EJ, Bush T, Young B. Relationship of depression and diabetes self-care, medication adherence and preventive care. Diabetes Care 2004, 27:2154-2160. 10.2337/diacare.27.9.2154, 15333477.
5. Katon WJ, Lin EH, Russo J, Von Korff M, Ciechanowski P, Simon G, Ludman E, Bush T, Young B. Cardiac risk factors in patients with diabetes mellitus and major depression. J Gen Intern Med 2004, 19:1192-1199. 10.1111/j.1525-1497.2004.30405.x, 1492592, 15610329.
6. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM. Depression and poor glycemic control: a meta analytic review of the literature. Diabetes Care 2000, 23:434-442. 10.2337/diacare.23.3.434, 10868892.
7. De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619-630.
8. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von Korff M. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005, 28:2668-2672. 10.2337/diacare.28.11.2668, 16249537.
9. Pouwer F, Beekman ATF, Lubach C, Snoek FJ. Nurses recognition and registration of depression, anxiety, and diabetes-specific emotional problems in outpatients with diabetes mellitus. Patient Educ Couns 2006, 60:235-240. 10.1016/j.pec.2005.01.009, 16442465.
10. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241-250.
11. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000, 23(5):618-623. 10.2337/diacare.23.5.618, 10834419.
12. Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521-529. 10.1001/archpsyc.63.5.521, 16651509.
13. Huang X, Song L, Li T. The effect of social support on type II diabetes with depression. Chinese Journal of Clinical Psychology 2001, 9:187-189.
14. Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1998, 129:613-621.
15. Williams JW, Katon W, Lin EH, Nöel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unützer J, . IMPACT Investigators The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004, 140:1015-1024. IMPACT Investigators.
16. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T. The Pathways study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004, 61:1042-1049. 10.1001/archpsyc.61.10.1042, 15466678.
17. Georgiades A, Zucher N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS. Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007, 69:235-241. 10.1097/PSY.0b013e318042588d, 17420441.
18. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression and quality of life. Diabetes Care 2004, 27:1066-1070. 10.2337/diacare.27.5.1066, 15111522.
19. Rapaport M, Clary C, Fayyad R, Endicott J. Quality of life impairment in depressive and anxiety disorders. Am J Psychiatry 2005, 162:1171-1178. 10.1176/appi.ajp.162.6.1171, 15930066.
20. Hegel MT, Oxman TE, Hull JG, Swain K, Swick H. Watchful waiting for minor depression in primary care: remission rates and predictors of improvement. Gen Hosp Psychiatry 2006, 28(3):205-212. 10.1016/j.genhosppsych.2006.02.008, 16675363.
21. Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand 2004, 109:325-331. 10.1111/j.1600-0447.2004.00301.x, 15049768.
22. Sadek N, Bona J. Subsyndromal symptomatic depression: a new concept. Depress Anxiety 2000, 12:30-39. 10.1002/1520-6394(2000)12:1<30::AID-DA4>3.0.CO;2-P, 10999243.
23. Cuijpers P, Smit F, Willemse G. Predicting the onset of major depression in subjects with subtreshold depression in primary care: a prospective study. Acta Psychiatr Scand 2004, 111:133-138.
24. Lyness JM, Heo M, Datto CJ, Ten Have TR, Katz IR, Drayer R, Reynolds CF, Alexopoulos GS, Bruce ML. Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med 2006, 144:496-504.
25. Paile-Hyvarinen M, Wahlbeck K, Eriksson JG. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract 2003, 4:7. 10.1186/1471-2296-4-7, 165418, 12747810.
26. Trozzolino L, Thomson PS, Tansman M, Azen SP. Effects of a psycho-educational group on mood and glycemic control in adults with diabetes and visual impairments. J Vis Impair Blind 2003, 97:230-239.
27. Pibernik-Okanovic M, Begic D, Ajdukovic D, Andrijasevic N, Metelko Z. Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial. Trials 2009, 10:78. 10.1186/1745-6215-10-78, 19709404.
28. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: Systematic review and meta-regression analysis of randomised controlled trials. BMJ 2001, 322:1-8. 10.1136/bmj.322.7289.763, 1119296, 11141128.
29. Lysy Z, Da Costa D, Dasgupta K. The association of physical activity and depression in Type 2 diabetes. Diabet Med 2008, 25:1133-1141. 10.1111/j.1464-5491.2008.02545.x, 19046190.
30. Lin EHB, Katon W, Rutter C, Simon GE, Ludman EJ, von Korff M, Young B, Oliver M, Ciechanowski PC, Kinder L, Walker E. Effects of Enhanced Depression Treatment on Diabetes Self-Care. Ann Fam Med 2006, 4:46. 10.1370/afm.423, 1466986, 16449396.
31. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823. 10.2337/diacare.27.3.813, 14988310.
32. Kolb H, Mandrup-Poulsen T. An immune origin of type 2 diabetes?. Diabetologia 2005, 48:1038-1050. 10.1007/s00125-005-1764-9, 15864529.
33. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008, 29:287-291. Minireview.
34. Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J. Effect of the addition of a "help"question to two screening questions on specifity for diagnosis of depression in general practice: diagnostic validity study. BMJ 2005, 331(7521):884. 10.1136/bmj.38607.464537.7C, 1255798, 16166106.
35. Poljicanin T, Pavlic-Renar I, Metelko Z. CroDiab NET - electronic diabetes registry. Acta Med Croatica 2005, 59:185-189.
36. Rohde P, Lewinshon PM, Seeley JR. Comparability of telephone and face-to-face interviews in assessing Axis I and II disorders. Am J Psychiatry 1997, 154:1593-1598.
37. Lewinsohn PM, Antonuccio DO, Steinmetz-Breckenridge JL, Teri L. The Coping with Depression course: A psychoeducational intervention for unipolar depression 1984, Eugene, OR: Castalia Publishing.
38. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192. (Letter), 10.2337/diacare.21.12.2191, 9839117.
39. Gavella M, Lipovac V, Car A, Vučić M, Sokolić L, Rakoš R. Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients. Acta Diabetol 2003, 40:95-100. 10.1007/s00592-003-0038-6, 12861408.